PMDA drug package insert
ミネラミック注
PMDA Prescription drug · 東和薬品株式会社 · package insert Nov 5, 2025
Key facts
| Brand names | ミネラミック注 |
|---|---|
| Nonproprietary names | 塩化マンガン・硫酸亜鉛水和物配合剤 |
| Companies | 製造販売元／東和薬品株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 高カロリー輸液用微量元素製剤 |
| Therapeutic category codes | 873229 |
| YJ codes | 3229501A1078 |
| Approval numbers | 21400AMZ00252 |
| Package insert edition | 第3版 |
| Package insert date | Nov 5, 2025 |
| PMDA document key | 480235_3229501A1078_1 |
| PMDA company code | 480235 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: